Healthcare -
Medical - Healthcare Plans - NYSE - US
$ 254.71
0.37 %
$ 30.7 B
Market Cap
25.55
P/E
1. INTRINSIC VALUE
Balance Sheet
Humana Inc.
| Current Assets | 29.8 B |
| Cash & Short-Term Investments | 20.4 B |
| Receivables | 2.7 B |
| Other Current Assets | 6.68 B |
| Non-Current Assets | 16.7 B |
| Long-Term Investments | 421 M |
| PP&E | 2.53 B |
| Other Non-Current Assets | 13.7 B |
| Current Liabilities | 16.9 B |
| Accounts Payable | 0 |
| Short-Term Debt | 577 M |
| Other Current Liabilities | 16.4 B |
| Non-Current Liabilities | 13.1 B |
| Long-Term Debt | 11.1 B |
| Other Non-Current Liabilities | 1.95 B |
EFFICIENCY
Earnings Waterfall
Humana Inc.
| Revenue | 118 B |
| Cost Of Revenue | 0 |
| Gross Profit | 118 B |
| Operating Expenses | 115 B |
| Operating Income | 2.56 B |
| Other Expenses | 1.35 B |
| Net Income | 1.21 B |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Humana Inc.
| Net Income | 1.21 B |
| Depreciation & Amortization | 968 M |
| Capital Expenditures | -575 M |
| Stock-Based Compensation | 207 M |
| Change in Working Capital | 154 M |
| Others | 1.44 B |
| Free Cash Flow | 2.39 B |
Wall Street Analysts Price Targets
Humana Inc.
Wall Street analysts predict an average 1-year price target for HUM of $328 , with forecasts ranging from
a
low of
$247 to a high of $419 .
HUM Lowest Price Target
Wall Street Target
247 USD
-3.03%
HUM Average Price Target
Wall Street Target
328 USD
28.85%
HUM Highest Price Target
Wall Street Target
419 USD
64.50%
4. DIVIDEND
ANALYSIS
0.35%
DIVIDEND YIELD
0.885 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Humana Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
949 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
The Big 3: ED, HUM, AWK
Aquiles Larrea turns to three companies he believes will withstand the storm of tariffs and swelling volatility. He talks about the upside potential he sees in Consolidated Edison (ED), Humana (HUM), and American Water Works (AWK).
youtube.com
- 2 weeks ago
Humana Inc. Announces Dates for First Quarter 2025 Earnings and June Investor Conference
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release financial results for the first quarter 2025 (1Q25) and host a live question-and-answer session on Wednesday, April 30, 2025. Additionally, the company will host an Investor Conference on Monday, June 16, 2025. 1Q25 Earnings Humana will release its 1Q25 financial results, as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 30, 2025. The company will host a live question-and-answer sessi.
businesswire.com
- 2 weeks ago
3 HMO Stocks to Watch Amid Nurse Shortages, High Tech Costs
The Medical-HMO industry rides on steady premium flows resulting from a growing customer base and contract wins. However, industry headwinds like elevated technology costs and workforce shortages remain concerns.
zacks.com
- 2 weeks ago
HUMANA ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Humana Inc. (NYSE: HUM) on behalf of long-term stockholders following a class action complaint that was filed against Humana on June 3, 2024 with a Class Period from July 27, 2022, to January 24, 2024.
globenewswire.com
- 2 weeks ago
AM Best Comments on Humana Inc.'s Re-Opened Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Long-Term Issue Credit Rating of “bbb” (Good) on the $1.25 billion 5.375% senior unsecured notes, due 2031, originally issued on March 13, 2024, by Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM] remains unchanged despite the additional notes being added as part of the same series. Humana has announced that it has issued an additional $250 million of senior unsecured notes under that offering, bringing the total t.
businesswire.com
- 2 weeks ago
Humana Gains on Strong Membership Base and Sound Cash Reserves
HUM benefits from a cost-effective health plan suite, continued expansion endeavors and a strong 2025 business outlook.
zacks.com
- 2 weeks ago
Humana's CenterWell Launches Gladstone Walmart Location for Seniors
The easy accessibility for patients will give HUM a competitive edge over other senior-focused healthcare providers.
zacks.com
- 4 weeks ago
CenterWell Bringing Convenient, Personalized Health Care to Seniors at Gladstone Walmart
GLADSTONE, Mo.--(BUSINESS WIRE)--CenterWell bringing convenient, personalized health care to seniors at Gladstone Walmart.
businesswire.com
- 1 month ago
Humana & Icon Enhance Senior Healthcare With Integrated Specialty Care
HUM's CenterWell and Conviva partner with Icon Health, improving musculoskeletal care access for seniors.
zacks.com
- 1 month ago
CenterWell, Icon Health Collaborate to Transform Musculoskeletal Care for Seniors
Specialty care model introduced first in Palm Beach County LOUISVILLE, Ky. and STAMFORD, Conn.
prnewswire.com
- 1 month ago
Humana Completes Aggregate $1.25 Billion Debt Offering
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of the company's 5.550 percent senior notes, due 2035, at 99.885 percent of the principal amount, and $500 million of the company's 6.000 percent senior notes, due 2055, at 98.951 percent of the principal amount (collectively, the “Senior Notes Offerings”).
businesswire.com
- 1 month ago
AM Best Assigns Issue Credit Ratings to Humana Inc.'s New Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb” (Good) to the $750 million, 5.5% senior unsecured notes, due 2035, and the $500 million, 6.0% senior unsecured notes, due 2055, issued by Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. The outlook assigned to these Credit Ratings (ratings) is stable. Humana's Long-Term Issuer Credit Rating of “bbb” (Good), its Long-Term IRs and the ratings of its insurance subsidiaries are unchange.
businesswire.com
- 1 month ago
8. Profile
Summary
Humana Inc. HUM
COUNTRY
US
INDUSTRY
Medical - Healthcare Plans
MARKET CAP
$ 30.7 B
Dividend Yield
0.35%
Description
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Contact
Humana Building, Louisville, KY, 40202
https://www.humana.com
IPO
Date
Dec. 31, 1981
Employees
65680
Officers
Dr. Sanjay K. Shetty M.B.A., M.D.
President of CenterWell
Mr. John-Paul William Felter
Senior Vice President, Chief Accounting Officer & Controller
Mr. Joseph C. Ventura
Chief Legal Officer
Mr. David E. Dintenfass
President of Enterprise Growth
Mr. James A. Rechtin M.B.A.
President, Chief Executive Officer & Director
Mr. Bruce Dale Broussard
Strategic Advisor
Mr. Japan A. Mehta
Chief Information Officer
Ms. Celeste M. Mellet
Chief Financial Officer
Mr. George Renaudin II
President of Insurance
Ms. Lisa M. Stoner
Vice President of Investor Relations